Wyoming Quit Tobacco Program Follow-Up Survey

Similar documents
Wyoming Quit Tobacco Program Follow-Up Survey

Wyoming Quit Tobacco Program Follow-Up Survey

2015 Wyoming Adult Tobacco Survey

ISSUE BRIEF. Limiting Youth Access to Tobacco Products. Summary

IOWA MEDICAID DRUG UTILIZATION REVIEW COMMISSION 100 Army Post Road Des Moines, IA (515) Fax

Adult Smoking Rate Declines in Wyoming

ELECTRONIC CIGARETTES WHAT S THE BOTTOM LINE?

Smoking stops declining and shows signs of increasing among younger teens

Cigarettes and Other Tobacco Products

Dawn S. Berkowitz, MPH, CHES Director, DHMH Center for Tobacco Prevention and Control 10 th Annual MDQuit Best Practices

SCL Health Tobacco Surcharge FAQs

Quit Rates of New York State Smokers

Tobacco Surcharge Frequently Asked Questions 2017

Adolescents and Tobacco Cessation

QuitlineNC Evaluation July 2008 June 2009

Evaluation of the Workplace-based Quit Smoking Programs. Intake Survey

Effective Treatments for Tobacco Dependence

E-cigarettes surpass tobacco cigarettes among teens

IOWA MEDICAID DRUG UTILIZATION REVIEW COMMISSION 100 Army Post Road Des Moines, IA (515) Fax

Arizona Youth Tobacco Survey 2005 Report

What Does the Independent Evaluation Tell Us About Getting Smokers To Quit?

Slide 1. Slide 2. Slide 3. Reducing Tobacco Use and Nicotine Dependence in Clinical Settings. Goals for Today

Maryland Tobacco Quitline 10 th Anniversary: Past, Present, and Future

Tobacco Cessation, E- Cigarettes and Hookahs

Is Vaping a Valid Strategy for Smoking Cessation? Myths and Facts Jaspreet S. Brar. MD, PhD Community Care Behavioral Health Organization

Tobacco Use. Overview. General Data Note. Summary NYSDOH

Nebraska Youth Tobacco Survey (YTS) 2018/2019 Questionnaire

2018 Tobacco/Smoke Free Affidavit

Centers for Disease Control and Prevention s Office on Smoking and Health

Fast Facts. Morbidity and Mortality (Related to Tobacco Use)

Evaluation of Colorado QuitLine outcomes among FY enrollees. January 2012

Project ECHO Importance of Treating Tobacco Use In People With Behavioral Health Disorders Jan Blalock, Ph.D.

Smoking Cessation: Where Are We Now? Nancy Rigotti, MD

First Annual Tobacco Study

These reports were prepared pursuant to directive contained in Section 10 of Senate File 2425 which is listed below:

What is Quitline Iowa?

Tobacco Use and Attitudes Survey. Montana Tech Students

North Carolina Health and Wellness Trust Fund. Quitline NC. Quitline NC Evaluation July 2007 June Prepared for:

A REPORT ON THE INCIDENCE AND PREVALENCE OF YOUTH TOBACCO USE IN DELAWARE

National Quitline Data Warehouse (NQDW): Changes to Data Collection in 2016

Quitline NC Evaluation November June 2007

Nebraska Youth Tobacco Survey 2015/2017

EVIDENCE-BASED INTERVENTIONS TO HELP PATIENTS QUIT TOBACCO

Sweet Cheap Easy to Get. Tobacco industry tactics. Introduction. Tobacco Industry Tactics 5/1/2018

NRT in Combination with Quitline Counseling: What Delivery and Protocol Design Methods are Working Best?

Trends in electronic cigarette use in England

Smoking Cessation in Pregnancy. Jessica Reader, MD, MPH Family Medicine Obstetrics Fellow June 1st, 2018

BASIC SKILLS FOR WORKING WITH SMOKERS

Decline in teen smoking continues into 2012

USING APPS TO HELP SMOKERS QUIT

TRENDS IN TOBACCO UNDERSTAND 5/26/2017 LEARNING OBJECTIVES. Understand the types of tobacco products trending in today s market & associated risks

Tobacco Cessation for Women of Reproductive Age. Erin McClain, MA, MPH

E-Cigarette Use Transitions: a Case Study from Waves 1 & 2 of the PATH Study

Community Perception of Electronic Cigarettes and Their Role as Smoking Cessation Aids

DISCLAIMER: ECHO Nevada emphasizes patient privacy and asks participants to not share ANY Protected Health Information during ECHO clinics.

Tobacco use assessment, brief counseling,, and quit line referral

State of Wyoming Department of Health

Sample Managed Care Organization Survey Questions to Assess Smoking Prevalence and Available Cessation Benefits

AHEC Tobacco Online Modules

Maryland Tobacco Control Program Successes. Donald Shell, MD, MA Interim Director DHMH, Center for Health Promotion Education, Tobacco Use Prevention

Innovative Approaches and Proven Strategies for Maximizing Reach: Case Studies to Highlight Promising and Best Practices

TOBACCO USE AMONG AFRICAN AMERICANS

Investment in Health: How Alabama s Tobacco Quitline Saves Lives (and Dollars)

Getting to Quit: Smoking Cessation Initiatives. Women in Government National Legislative Conference June 22, 2018

Smoking, e-cigs and reduced risk products. Dr John Schoonbee, IMS November 2017

You Can Make a Difference!

BASIC SKILLS FOR WORKING WITH SMOKERS

Preventing Youth Electronic Cigarette Use: Partnering with Schools

Quitting smoking is hard

E-Cigarettes & Vaping. Information for Women & Their Families

1st Annual Tobacco and Nicotine

Creative Systems Change: Oklahoma Tobacco Helpline Integration with Crisis Helpline

Workplace Quit Smoking Program 12-month Follow-up Survey:

4/2/2015. Inpatient Smoking Cessation. Smoking Cessation Documentation Patient's Stage of Behavior Change

CAMPUS SMOKING POLICY

The Latest on Vaping Among U.S. Teens

Sacramento City College Smoke/Tobacco/Vape (STV) Free Environmental Standard

Disparities in Tobacco Product Use in the United States

Indiana Cancer Control Plan,

UNITED STATES REGULATION OF TOBACCO PRODUCTS. Presented by Mitch Zeller Center Director FDA Center for Tobacco Products

Web enrollment and self assessment for NRT: feasibility and quit rates

Tobacco Control Highlights Wisconsin

Improving E-Cigarette Research through Measurement and Design ANDREA VILLANTI, PHD MPH E-CIGARETTE SUMMIT MAY 8, 2017

Introduction, Summary, and Conclusions

Data Highlights from the 2013 Hawai'i Youth Tobacco Survey (YTS) and Comparisons with Prior Years

SMOKING CESSATION ASSESSMENT AND INTERVENTIONS. Role for Support Groups

SUNSET Russian Tobacco Education: Evaluating Quit Clinics

Tobacco Control Highlights Alaska

Providing Tobacco Cessation Support in a State Correctional Facility

Impact of UNC Health Care s Tobacco-Free Hospital Campus Policy on Hospital Employees

Tobacco Use in Adolescents

TOBACCO USE 2011 SURVEY RESULTS REPORT AND RELATED BEHAVIORS. Figure 1 n Trends in current tobacco use, Grades 9 12, New Mexico,

Evaluating Interventions to Curb ENDS Use Among Utah Youth

Reducing Tobacco Use and Secondhand Smoke Exposure: Quitline Interventions

Utah Youth Media Survey Final Instrument for Welcome to the Utah Youth Media Survey and thanks for your participation! Please make sure to:

Tobacco Product Use Among Middle and High School Students United States,

Asthma Educator Sharing Day October 28, 2016

Transcription:

June 29, 2017 Wyoming Quit Tobacco Program Follow-Up Survey July December 2016 Interviews Muneyuki Kato, MA, Associate Research Scientist Tiffany Comer Cook, MS, Senior Research Scientist Laran H. Despain, PhD, Associate Research Scientist Wyoming Survey & Analysis Center University of Wyoming 1000 E. University Avenue, Department 3925 Laramie, Wyoming 82071 307.766.2189 wysac@uwyo.edu www.uwyo.edu/wysac

ABOUT THIS REPORT Under contract to Wyoming Department of Health, Public Health Division 6101 Yellowstone Road, Suite 420 Cheyenne, WY 82002 (307) 777-6340 This publication was supported by tobacco settlement funds. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the Wyoming Department of Health. CITATION WYSAC. (2017). Wyoming Quit Tobacco Program follow-up survey: July December 2016 interviews by M. Kato, T. C. Cook, & L. H. Despain. (WYSAC Technical Report No. CHES-1707). Laramie, WY: Wyoming Survey & Analysis Center, University of Wyoming. 2017 2 UNIVERSITY OF WYOMING

Contents Background... 4 Enrollee Information... 5 WQTP Outcomes... 8 Special Section: Free Chantix and the WQTP... 10 Enrollment... 11 Component Use... 11 Program Success... 12 Priority Populations... 13 Alternative Nicotine Product Users... 13 Mental Health... 14 Pregnant Women... 15 American Indians... 15 Enrollee Reports on Strengths and Weaknesses of the WQTP... 16 Conclusions... 16 References... 18 UWYO.EDU/WYSAC 3

Background The Wyoming Quit Tobacco Program (WQTP) assists enrollees in their efforts to quit using tobacco products by offering free Quitline phone coaching, free nicotine replacement therapy (NRT), and free or reduced-price prescription (Rx) medications. In the middle of February 2016, the WQTP began offering free Chantix (one of the prescription medications) to enrollees. Providing cessation services to Wyoming residents is an important part of the state s Tobacco Prevention and Control Program (TPCP). Wyoming follows the Centers for Disease Control and Prevention (CDC) guidelines for state tobacco prevention programs (CDC, 2015b). Figure 1 shows how the WQTP and the data presented in this report fit into the goals of Wyoming s TPCP, with highlighted boxes showing the most relevant parts of CDC s logic model for cessation. Figure 1: Logic Model for Wyoming s Tobacco Cessation Goals Source: CDC 2015b (p. 21). Highlighting added. 4 UNIVERSITY OF WYOMING

Under contract to the Wyoming Department of Health, Public Health Division, the Wyoming Survey & Analysis Center (WYSAC) at the University of Wyoming conducts monthly surveys of WQTP enrollees to assess quit rates and enrollee satisfaction. The survey also assesses enrollees use of Quitline coaching, NRTs, or prescription medications and enrollees opinions of different program elements. This report includes data on WQTP participants surveyed between July and December 2016, seven months after they enrolled in the WQTP. These participants enrolled in the WQTP between December 2015 and May 2016. During this period, National Jewish Health provided WQTP services in Wyoming. Enrollee Information How many people did WQTP serve between December 2015 and May 2016? Figure 2 provides the monthly enrollment for December 2015 May 2016. For comparison, this figure also shows the same months from the previous year. Enrollees may sign up by completing an intake survey online or by phone. The number of enrollments in January 2016 was unusually low. However, the enrollment between February and May was higher in 2016 than in 2015. This increase coincides with the offer of free Chantix for enrollees, which began in mid-february 2016. Meanwhile, the Wyoming TPCP ran a Quit It media campaign in January, February, and March 2016 and advertised free Chantix from mid-april to the end of September 2016. The CDC also ran a 20-week Tips From Former Smokers media campaign in 2015 (launched March 30, 2015; CDC, 2015a) and 2016 (launched January 25, 2016; CDC, 2016). Overall, the WQTP enrolled 610 more participants between December 2015 and May 2016 (2,010 enrollees in total) than the same months from the previous year (1,400 enrollees in total). Figure 2: Enrollment between February and May Was Higher in 2016 than 2015 Total enrollees by month 2014 146 2015 142 2015 359 2016 268 Note: Total enrollees include those who completed only the intake process, those who had at least one Quitline coaching call, and those who enrolled only for WQTP online services. 422 277 Source: National Jewish Health Monthly Report. 338 236 426 414 Dec Jan Feb Mar Apr May 218 164 UWYO.EDU/WYSAC 5

Table 1: More than One Third of Eligible Respondents Completed the 7- Month Follow-Up Survey Response rate by follow-up month Intake survey month Follow-up survey month Dec 2015 Jan 2016 Feb Mar Apr May Jul 2016 Aug Sep Oct Nov Dec Total Total eligible respondents* Total complete interviews 105 204 309 229 292 300 1,439 33 75 115 91 101 108 523 Response rate 31% 37% 37% 40% 35% 36% 36% * Total eligible respondents includes all persons who were 18+ years old, provided a phone number on the WQTP intake questionnaire seven months previously, enrolled in the WQTP, and had an in-service phone number at the time of the survey. It excludes those who did not wish to be contacted for the follow-up survey. For those who enrolled more than once within a six-month timeframe, WYSAC used the date of the first enrollment to determine eligibility for a follow-up interview. How many enrollees completed the follow-up survey? The July December 2016 follow-up survey data include responses from 523 completed interviews (Table 1), a 36% response rate. Figure 3: Most Enrollees Enrolled to Quit Cigarettes Percentage of enrollees who wanted to quit using Which type of tobacco products did enrollees want help quitting? Enrollees could choose more than one option, but almost nine out of 10 enrolled in the WQTP to get help with quitting cigarettes (Figure 3). Cigarettes 89% Smokeless tobacco 14% Other tobacco 6% Note: n=523. Smokeless tobacco includes chewing tobacco, snuff, and dip. Other tobacco includes cigars, cigarillos, little cigars, electronic nicotine delivery systems (ENDS), and pipes. Percentages do not add to 100% because enrollees could choose more than one option. 6 UNIVERSITY OF WYOMING

Which program components were enrollees most likely to use? The Quitline was the most commonly used of the three major program components (Quitline, NRTs, and prescription medications; Figure 4). Most enrollees used NRTs, which are mailed to enrollees homes for free. Enrollees can order NRTs by going through the Quitline phone coaching or the online support program. In mid-february 2016, the WQTP began offering free Chantix to enrollees. This report includes data from people who enrolled before and after this programming change. (See Special Section: Free Chantix and the WQTP for details related to the offer of free Chantix.) Enrollees can order prescription medications only by going through the Quitline phone coaching. Over one quarter of enrollees used prescription medications such as Chantix. Prescription medications, which require a prescription from a physician, were the least commonly used of the three major components. Relatively few enrollees, 26 (5%), reported not using any program component (i.e., none of the above). These enrollees may have completed the intake questionnaire without participating in any other program component. Because these responses are self-reported, respondents perspectives or memories about using the program may differ from National Jewish Health s administrative records. Still, these enrollees form a useful comparison group for gauging the effectiveness of different program components. Figure 4: Most Enrollees Used Quitline and Medication Services Percentage of enrollees who had used Note: n=523. Percentages do not add to 100% because enrollees could choose more than one option except none of the above. Quitline NRTs Rx medications Written materials Online program Texting program Other None of the above 1% 5% 28% 25% 39% 35% 59% 71% UWYO.EDU/WYSAC 7

WQTP Outcomes Figure 5: Nearly One Third of Enrollees Were Quit for 30 Days Percentage of enrollees who had not used any tobacco in the past 7 or 30 days Quit for 7 days Quit for 30 days Note: n=523. 30% 37% Figure 6: Enrollees Who Used Quitline & Rx Medication Had the Highest 30-Day Quit Rate Percentage of enrollees who had not used any tobacco in the past 30 days by WQTP services used Quitline & Rx medication (n=97) Quitline & NRT (n=174) Quitline & NRT & Rx medication (n=50) Web NRT only (n=83) Quitline only (n=50) Neither Quitline nor medication (n=66) Note: Use of Rx medication requires use of Quitline. Rx medication in this figure includes Chantix, and Zyban/Wellbutrin. 24% 22% 20% 30% 28% 46% Were enrollees successful in their cessation effort? The follow-up survey asked enrollees if they had used any tobacco products in the previous seven days. If they had not, the survey asked if they had used any tobacco products in the previous 30 days. For this sixmonth period, 37% of enrollees were quit for seven days; 30% were quit for 30 days (Figure 5). Which program component was most effective? The best outcome was associated with those who used both Quitline coaching and prescription medications. These enrollees had the highest 30-day quit rate (46%), seven months after enrollment (Figure 6). Few enrollees use prescription medications other than Chantix. A separate WQTP Follow-Up Survey item asked, Since you enrolled in the Wyoming Quit Tobacco Program, have you used any of the following prescription medications? Unless they said none of the above, enrollees could choose more than one option for this question. Relatively few enrollees, 27, reported using bupropion (including the specific brands Zyban and Wellbutrin), compared to 146 enrollees who reported using Chantix. WQTP enrollees are a unique subpopulation of Wyoming tobacco users trying to quit. They are more likely to be successful in quitting than the broader population of Wyoming tobacco users. As a reference point, 8 UNIVERSITY OF WYOMING

only 8% of Wyoming cigarette smokers have successfully quit without enrolling in the WQTP or using other cessation aids. That is, of those who have smoked in the past 6 months and made a recent quit attempt for 24 hours or longer without using any cessation aids, 8% were abstinent from cigarettes for at least 30 days at the time of the survey (WYSAC, 2017). Compared to Wyoming cigarette smokers who made a recent quit attempt without using any cessation aids, WQTP enrollees who did not use the core program components were approximately 2.5 times more likely to quit. Using different core components increases that difference. Enrollees who used phone coaching and prescription medications (the most successful group of enrollees) were approximately 5.8 times more likely to quit than Wyoming smokers who made a recent quit attempt without using cessation aids. Did those who did not quit make progress toward cessation? WYSAC asked those who had not quit about changes in tobacco consumption and quit attempts (stopping the use of tobacco for 24 hours or longer since enrolling in the WQTP). Over half reported using less tobacco compared to three months prior to the survey, and 82% reported making at least one quit attempt since enrolling (Figure 7). How satisfied were enrollees with the service they received from the WQTP? About one fourth (23%) were mostly satisfied, and 56% were very satisfied with the WQTP. 1 Almost two thirds (64%) reported that they had recommended the program to someone else (Figure 8). Figure 7: Most Enrollees Who Had Not Quit Made Progress toward Cessation Of enrollees who were not quit, percentage who Used less tobacco than 3 months prior (n=364) Made at least 1 quit attempt (n=346) Figure 8: Satisfaction with the WQTP Was High Percentage of enrollees who Were very or mostly satisfied (n=511) 54% 82% 80% Had recommeded WQTP (n=519) 64% 1 Total from these numbers (79%) and the total in Figure 8 (80%) do not match because of rounding. UWYO.EDU/WYSAC 9

Special Section: Free Chantix and the WQTP Figure 9: Online Ad for Free Chantix Source: The Wyoming Department of Health In mid-february 2016, the WQTP expanded its program by offering Chantix at no cost to the enrollees (enrollees were still responsible for covering the cost of a doctor s visit to obtain the prescription). In mid-april, the Wyoming TPCP began advertising this free Chantix offer (Figure 9). This special section examines the impacts of free Chantix on WQTP enrollment, program component use, and outcomes for those who enrolled between December 2015 and May 2016. WYSAC divided the six months of enrollees into three groups. The first group, participants who enrolled in December 2015 and January 2016, are participants who did not enroll when free Chantix was an option. The second group, participants who enrolled in February and March 2016, was identified to account for the midmonth launch of the offer, any logistical issues that may have arisen during the first two months of the free Chantix program, and delay between the offer of free Chantix and people knowing about the offer (e.g., the mid-april launch date for related media). The third group, participants who enrolled in April and May 2016, enrolled when the offer was fully in place and being actively advertised. Figures in this special section show estimates for WQTP enrollees in each of these three groups. 10 UNIVERSITY OF WYOMING

Enrollment Did the offer of free Chantix affect enrollment? Figure 10 shows the average number of enrollments for the three groups. The relatively high enrollment in WQTP from February through May 2016 coincides with the offer of free Chantix. On average, the enrollment for these months in 2016 was higher than the previous year. Additionally, the media used to promote the free Chantix program, and thus the WQTP (starting in mid-april 2016), coincides with sustained high enrollment, unlike the previous year. We cannot determine how much of the change in enrollment is the result of the free Chantix, general WQTP promotional media, media promoting the free Chantix, or other promotions such as the CDC Tips campaign or word of mouth. Figure 10: The Average Enrollment Was Highest in the Months the WQTP offered Free Chantix The average number of enrollees 2014-15 253 2015-16 205 Note: Total enrollees include those who completed only the intake process, those who had at least one Quitline coaching call, and those who enrolled only for WQTP online services. Source: National Jewish Health Monthly Report. 380 2016 420 257 2015 191 Dec - Jan Feb - Mar Apr - May Component Use Did the offer of free Chantix affect the use of WQTP components? During the sixmonth period described in this report, the use of prescription medications such as Chantix increased after the WQTP started offering free Chantix. Simultaneously, the use of NRTs decreased (Figure 11). This shift was relatively Figure 11: Prescription Medication Use Increased in the Months the WQTP Offered Free Chantix Percentage of enrollees who had used NRTs 66% 66% Rx medications 18% 22% 49% 40% Dec 15 - Jan 16 Feb - Mar 16 Apr - May 16 Note: Dec 15 Jan 16: n=108; Feb Mar 16: n=205; Apr May 16: n=209. Enrollees could choose more than one option. UWYO.EDU/WYSAC 11

slight in the first two months of offering free Chantix and greater in the last two months of data. It is reasonable to tie the increased use of prescription medications to the offering of free Chantix (relatively few enrollees used other prescription medications). It may also be that people opted for Chantix instead of NRT when both were free (ignoring the cost of a physician visit to obtain a prescription for Chantix). Program Success What is the quit rate for Chantix users? Enrollees (n = 107) who used Chantix (with no other NRTs or Rx medications) had the highest 30-day quit rate (47%). 2 This is compared to those who used Quitline only (22%), those who used NRTs through the online program (24%), and those who used Quitline and NRTs (30%). Did the effectiveness of Chantix improve the overall quit rate? Although Chantix users usually have a relatively high quit rate, overall program quit rate does not seem to depend on the status of free Chantix. The overall quit rates for the two months before offering free Chantix (30%), the first two months of the offer (27%), and the last two months of data (33%) are all fairly similar. Overall program satisfaction was also fairly stable across the three time periods. 2 This differs from the 46% reported in Figure 6 because that quit rate includes enrollees who used any prescription medication, including Chantix and Zyban/Wellbutrin. 12 UNIVERSITY OF WYOMING

Priority Populations In addition to overall outcomes, this report provides follow-up data on four priority populations: those who used alternative nicotine products (such as electronic nicotine delivery systems [ENDS]), those who reported mental health conditions, those who participated in the pregnancy program, and those who participated in the American Indian Commercial Tobacco Program (AICTP). Alternative Nicotine Product Users ENDS such as e-cigarettes, e-hookahs, and vape pens are battery-operated devices that simulate smoking but do not involve the burning of tobacco. The heated aerosol produced by ENDS often contains nicotine and comes in different flavors. Have enrollees ever used ENDS or other similar nicotine products? If so, why did they use them? Over half (52%) of enrollees had used ENDS in their lifetime (Figure 12). Moreover, 83% of enrollees who had used ENDS used them to quit or cut-down on other tobacco although they are not approved as cessation aids by the U.S. Food and Drug Administration (FDA, 2016). Only two enrollees had used another alternative nicotine product (such as Nicogel, orbs, or Camel strips) that is not approved as a smoking cessation product. Figure 12: Over Half of Enrollees Had Used ENDS for Various Reasons Percentage of enrollees Not using now, but had used to quit other tobacco 23% Not using now, but had used to cut down on other tobacco 14% Using now to quit other tobacco Using now to cut down on other tobacco Not using now, but had used for some other reason Using now for some other reason 4% 3% 7% 2% Never used 48% Note: n=522. Percentages do not total 100% because of rounding. UWYO.EDU/WYSAC 13

Mental Health Studies (e.g., CDC, 2013; Talati, Keyes, & Hasin, 2016) have demonstrated an association between cigarette smoking and mental health conditions. People with mental health conditions are more likely to smoke and to smoke more cigarettes than people without mental health conditions (CDC, 2013). Based on combined data from the 2009 2011 National Survey on Drug Use and Health (NSDUH), 37% of Wyoming adults who had a mental health condition had smoked part or all of a cigarette within the 30 days prior to being surveyed, compared to 23% of Wyoming adults without a mental health condition (CDC, 2013). 3 In the intake survey, enrollees answered questions about their mental health. The intake questionnaire asks, Do you have any mental health conditions, such as anxiety disorder, Figure 13: Enrollees Reporting Mental Health Conditions Were Less Likely to Use Prescription Medications Percentage of enrollees, by mental health condition, who had used different WQTP services Any MH condition Rx medications 21% depression disorder, bipolar disorder, alcohol/drug abuse, 3 or schizophrenia? WYSAC merged responses to this mental health question at intake with the followup survey data; 512 follow-up survey respondents had answered the question. Of these respondents, 36% said they had a mental health condition at the time of the intake survey. No MH condition 32% How did key program component usage NRTs rates differ for enrollees who reported Any MH condition 62% mental health conditions? Enrollees who reported mental health conditions were less No MH condition 58% likely to use prescription medications but Any MH condition Quitline 75% slightly more likely to use the Quitline and NRTs, compared to those who did not report mental health conditions. (Figure No MH condition 70% 13). Note: n for Any MH condition=182; n for No MH condition=329. One participant who answered the question about mental health was not sure about component use. Sources: WQTP Intake and Follow-Up Surveys. 3 In the NSDUH, a mental health condition was defined as having a mental, behavioral, or emotional disorder, excluding developmental and substance use disorders, in the past 12 months. This definition differs from the WQTP intake survey question, which includes alcohol/drug abuse. 14 UNIVERSITY OF WYOMING

Did outcomes differ for people with mental health conditions? Those with mental health conditions were less likely to have been quit for 30 days, compared to those who did not report such conditions. All other outcomes had only a small difference between enrollees who reported mental health conditions and those who did not report such conditions (Figure 14). Pregnant Women Smoking is linked to complications during pregnancy, including miscarriage and birth defects (CDC, 2015c). These excess risks make pregnant women a priority population for the Wyoming TPCP. Eleven enrollees said they were pregnant at the time of enrollment. None of these enrollees responded to the follow-up survey. American Indians Figure 14: Enrollees with Mental Health Conditions Had a Lower Quit Rate Any MH condition (n=182) No MH condition (n=330) Any MH condition (n=144) No MH condition (n=211) Any MH condition (n=139) No MH condition (n=199) Any MH condition (n=178) No MH condition (n=322) Any MH condition (n=180) No MH condition (n=328) Quit for 30 days 20% 36% Used less than 3 months prior 55% 54% Made at least 1 quit attempt Very or mostly satisfied Had recommended WQTP 66% 63% 80% 83% 78% 81% On August 1, 2015, National Jewish Health began offering the American Indian Commercial Tobacco Program (AICTP) to provide a culturally-sensitive approach to Source: WQTP Intake and Follow-Up Surveys. help American Indians quit commercial tobacco use (National Jewish Health, 2015). One of the seven American Indians who enrolled in the AICTP completed the follow-up survey. The small sample size means that it is not possible to generalize the results to all American Indian enrollees. UWYO.EDU/WYSAC 15

Enrollee Reports on Strengths and Weaknesses of the WQTP Figure 15: Most Enrollees Reported No Problems with Using the WQTP Percentage of enrollees who had any of the following problems with the Wyoming Quit Tobacco Program Difficulty contacting the program by telephone Difficulty accessing the program on the Internet Difficulty getting Rx medications 6% 16% 10% What did enrollees report about the strengths and weaknesses of the WQTP? Most enrollees (72%) reported no problems with using the core program components (Figure 15). Among those who reported difficulty, contacting the program by telephone was the most problematic, followed by acquiring NRT products and prescription medications. Conclusions Difficulty acquiring NRT products None of the above Note: n=518. Percentages do not add to 100% because enrollees could choose more than one option except none of the above. 11% The data for WQTP enrollees who completed the follow-up survey between July and December 2016 (meaning they enrolled between December 2015 and May 2016) show that roughly nine out of 10 program participants enrolled to get help with quitting cigarettes. Most enrollees used the Quitline. In addition, compared to the previous semiannual report (WYSAC, 2016), prescription medication use increased from 17% to 28% while NRT use decreased from 72% to 59%. Detailed analyses indicate that these shifts in program use coincided with the offer of free Chantix beginning in February 2016. 72% Depending on what core components they use (if any), adults who enroll in the WQTP are about 2.5 to 5.8 times more likely to quit than Wyoming adults who try to quit smoking without enrolling in the WQTP or using other cessation aids, who have an 8% quit rate. Nearly one third (30%) of enrollees reported being quit for at least 30 days. This quit rate is slightly higher than the 30-day quit rate (26%) reported in the previous semiannual report (WYSAC, 2016). Those who used Quitline coaching and any prescription medication (including Chantix and Zyban/Wellbutrin) had the highest 30-day quit rate (46%). The quit rate for enrollees who used Quitline coaching and Chantix but not Zyban/Wellbutrin was virtually the same (47%). 16 UNIVERSITY OF WYOMING

Satisfaction with WQTP was high: 80% of enrollees reported being very or mostly satisfied with the program, and the majority (64%) had recommended the WQTP to someone else. Data from the previous semiannual report indicated similar high levels of program satisfaction. The majority (72%) of respondents reported no problems with the WQTP. Among those who reported difficulty, contacting the program by telephone was the most problematic, followed by acquiring NRT products and prescription medications. WYSAC analyzed follow-up data for four priority populations: those who used alternative nicotine products such as ENDS, those who reported mental health conditions, those who participated in the pregnancy program, and those who participated in the AICTP. More than half (52%) of enrollees had used ENDS in their lifetime. Of these, 83% had used them to quit or cut-down on other tobacco even though they are not approved as cessation aids by the FDA (2016). Enrollees reporting mental health conditions were less likely to use prescription medications and to be quit for 30 days than those reporting no such conditions. The sample sizes for those in the pregnancy program and the AICTP are too small to draw conclusions about those programs or to generalize to other WQTP enrollees. The follow-up data show that WQTP program components successfully help enrollees quit. The increased use of these components, especially prescription medications such as Chantix, would likely increase the overall success of the program. UWYO.EDU/WYSAC 17

References Centers for Disease Control and Prevention. (2013). Vital signs: Current cigarette smoking among adults aged 18 years with mental illness United States, 2009 2011. MMWR, 62(5), 81-87. Centers for Disease Control and Prevention. (2015a). Powerful new Tips From Former Smokers ads focus on living with vision loss and colorectal cancer. Retrieved March 9, 2017, from https://www.cdc.gov/media/releases/2015/p0326-tips.html Centers for Disease Control and Prevention. (2015b). Promoting quitting among adults and young people: outcome indicators for comprehensive tobacco control programs 2015. Atlanta, GA: Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health. Centers for Disease Control and Prevention. (2015c). Reproductive health: Tobacco use and pregnancy. Retrieved November 6, 2015, from http://www.cdc.gov/reproductivehealth/maternalinfanthealth/tobaccousepregnancy/ind ex.htm Centers for Disease Control and Prevention. (2016). CDC s national tobacco education campaign: 2016 Tips campaign Overview. Retrieved March 9, 2017, from https://www.cdc.gov/tobacco/campaign/tips/partners/php/materials/tips-campaignoverview-2016.pdf National Jewish Health. (2015). National Jewish Health launches commercial tobacco program customized for American Indians. Retrieved from https://www.nationaljewish.org/health-initiatives/news-resources-(1)/national-jewish- Health-Launches-Commercial-Tobacco-Program-Customized-for-A Talati, A., Keyes, K. M., & Hasin, D. S. (2016). Changing relationships between smoking and psychiatric disorders across twentieth century birth cohorts: Clinical and research implications. Molecular Psychiatry, 21, 464 471. doi:10.1038/mp.2015.224 U.S. Food and Drug Administration. (2016). Vaporizers, e-cigarettes, and other electronic nicotine delivery systems (ENDS). Retrieved September 21, 2016, from http://www.fda.gov/tobaccoproducts/labeling/productsingredientscomponents/ucm45 6610.htm WYSAC. (2016). Wyoming Quit Tobacco Program follow-up survey: January June 2016 interviews, by M. Kato, T. C. Cook, & L. H. Despain. (WYSAC Technical Report No. CHES-1614). Laramie, WY: Wyoming Survey & Analysis Center, University of Wyoming. WYSAC. (2017). 2015 Wyoming Adult Tobacco Survey [Data file]. 18 UNIVERSITY OF WYOMING